Skip to main content
IONS
NASDAQ Life Sciences

Ionis Slashes 2026 Tryngolza Guidance, Shares Sink Toward 52-Week Low

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$28.665
Mkt Cap
$4.764B
52W Low
$27.75
52W High
$86.74
52W Position info
3.3% above low
Off High info
67% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

IONS is trading near its 52-week low of $27.75 (3.3% above the low) on elevated volume (1.9× avg).

Summary

Ionis cut its 2026 TRYNGOLZA sales guidance to about $100 million, disclosed alongside Q3 revenue of $243 million and a $0.66 per-share loss. The stock is falling hard and now trades near its 52-week low of $27.75, down from a high of $86.74. The problem is concentrated: the 10-Q shows DAWNZERA offsetting a sharp TRYNGOLZA decline, so the launch that was supposed to anchor the commercial story is undershooting. This lands just weeks after CHMP recommended EU approval of TRYNGOLZA in severe hypertriglyceridemia, which makes the US demand shortfall the more glaring issue. The rest of the pipeline has been delivering — zilganersen approved in September, positive Phase 3 data for ulefnersen and sefaxersen — but those are partner-driven or early-revenue assets, and pelacarsen's Phase 3 failure already removed one royalty stream.

At the time of this announcement, IONS was trading at $28.67 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.8B. The 52-week trading range was $27.75 to $86.74. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

IONS - Latest Insights

IONS
Nov 09, 2026, 8:33 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.50
Real-time Price: $29.22 info
Change: -$2.29 (-7%) info
Market Cap: $4.855B info
IONS
Nov 09, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.00
Real-time Price: $29.22 info
Change: -$7.79 (-21%) info
Market Cap: $4.855B info
IONS
Nov 09, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $37.00
Real-time Price: $29.22 info
Change: -$7.79 (-21%) info
Market Cap: $4.855B info
IONS
Oct 23, 2026, 1:41 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $42.93
Real-time Price: $29.22 info
Change: -$13.72 (-32%) info
Market Cap: $4.855B info
IONS
Oct 20, 2026, 9:20 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $45.20
Real-time Price: $29.22 info
Change: -$15.99 (-35%) info
Market Cap: $4.855B info